Clinical Trial Update: The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

View source ↗

Summary

An ongoing clinical trial is evaluating the long-term safety and effectiveness of the QDOT MICRO System used with the VISITAG SURPOINT Module for treating sympt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Drugs mentioned

• QDOT MICRO System
• VISITAG SURPOINT Module

Snippet

Sponsor: Heart Rhythm Clinical and Research Solutions, LLC | Conditions: Paroxysmal Atrial Fibrillation | Status: RECRUITING